Trump Administration Accelerates Psychedelic Drug Research for Mental Health Treatment
President Donald Trump signed an executive order in April aimed at fast-tracking research into psychedelic drugs like MDMA to treat mental health conditions such as PTSD and depression. The move includes granting priority review vouchers to three companies developing these therapies, signaling a shift from previous administration policies.
Tickers: $CMPS